Richard T Lee1, Jan Lammerding
1Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Matrix metalloproteinase inhibition may prevent heart failure by targeting ventricular dilation. Further research into cell-matrix interactions and bioengineering tools is crucial for developing new therapies.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: